Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023–2024
Authors' conclusion
The registry demonstrated suboptimal control rates for cardiovascular risk factors among Chinese T2DM patients, underscoring the imperative need for implementing guideline-directed management.
Study context
- Population
- Adults with T2DM in China, recruited from 60 hospitals (registry of adults with T2D and/or hypertension (HTN), heart failure (HF) or CKD, 110 hospitals)
- Participants
- 9,000 adults60 hospitals
- Outcome
- Control of cardiovascular risk factors (HbA1c, blood pressure, LDL-C) in baseline T2DM cohort
- Follow-up
- Baseline
Methodological detailsmulticentric, baseline cross-sectional analysis, Data collected every 6 months
- Multicentric
- Baseline cross-sectional analysis
- Data collected every 6 months
Main finding
As reported in the abstract
- Mean HbA1c
- 8.5 ± 2.2%
- Achieved HbA1c <7.0%
- 29.0%
- Average blood pressure
- 131/81 mmHg
- Reached blood pressure <130/80 mmHg
- 27.8%
- Mean low-density lipoprotein cholesterol (LDL-C)
- 2.8 ± 1.0 mmol/L
- Achieved LDL-C <2.6 mmol/L
- 43.0%
- Achieved all three targets (HbA1c, blood pressure, LDL-C)
- 5.0%
Observational data: associations, not effects.
Original publication
Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023–2024. Diabetes Obes Metab. Published 27 October 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →